Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence von van Heuckelum, M, Linn, A J, Vandeberg, L, Hebing, R C F, van Dijk, L, Vervloet, M, Flendrie, M, Nurmohamed, M T, van Dulmen, S, van den Bemt, B J F, van den Ende, C H M

Volltext

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up von Vogelzang, E H, Hebing, R C F, Nurmohamed, M T, van Kuijk, A W R, Kruijff, J W F, l'Ami, M J, Krieckaert, C L M, Wolbink, G

Volltext

Methotrexate Polyglutamates Exposure – Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate von Hebing, Renske C. F., Bartelink, Imke H., Gosselt, Helen R., Heil, Sandra G., Rotte, Mauritis C. F. J., Jong, Pascal H. P., Nurmohamed, Mike T., Jonge, Robert, Mathôt, Ron A. A.

Volltext

Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trial von Hebing, Renske CF, Aksu, Iremnur, Twisk, Jos WR, Bos, Wouter, Van den Bemt, Bart, Nurmohamed, Michael T

Volltext